Peptides DB
Research-centric peptide and protocol reference hub
ReutersNovember 9, 2026Regulatory

US FDA orders new eye risk warnings for Ozempic, Zepbound

Reported by Reuters. Read the original →

What the story says

The US FDA has issued new eye risk warnings for the medications Ozempic and Zepbound, which contain the compound semaglutide.

Summarised by a model from Reuters's headline and its own description of the story. We did not read the article, and this is not our reporting — the link above is.

On file here

Every number below is counted from this library's own approved studies — the ones with a page you can open and check. Counts move as papers are filed.

What the headline doesn't tell you

  • Semaglutide has 62 studies on file, 34 of them in humans, the newest published 2026.

Counted, not written: each line is a sentence filled in from the study counts above. None of it is a judgement about the story or the compound.